{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:10:22Z","timestamp":1793247022914,"version":"4.5.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1212\/wnl.52.8.1673","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:39:44Z","timestamp":1336916384000},"page":"1673-1673","source":"Crossref","is-referenced-by-count":225,"title":["Antiparkinsonian effect of a new selective adenosine A<sub>2A<\/sub>receptor antagonist in MPTP-treated monkeys"],"prefix":"10.1212","volume":"52","author":[{"given":"R.","family":"Grondin","sequence":"first","affiliation":[{"name":"From the Neuroscience Research Unit (Drs. GrondinBe\u0301dard, and Hadj Tahar, and L. Gre\u0301goire), Laval University Research Center, Quebec, Canada; and Pharmaceuticals Research and Development Center (Drs. Mori and Kase), Kyowa Hakko Kogyo Co., Ltd., Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"Be\u0301dard","sequence":"additional","affiliation":[{"name":"From the Neuroscience Research Unit (Drs. GrondinBe\u0301dard, and Hadj Tahar, and L. Gre\u0301goire), Laval University Research Center, Quebec, Canada; and Pharmaceuticals Research and Development Center (Drs. Mori and Kase), Kyowa Hakko Kogyo Co., Ltd., Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Hadj","family":"Tahar","sequence":"additional","affiliation":[{"name":"From the Neuroscience Research Unit (Drs. GrondinBe\u0301dard, and Hadj Tahar, and L. Gre\u0301goire), Laval University Research Center, Quebec, Canada; and Pharmaceuticals Research and Development Center (Drs. Mori and Kase), Kyowa Hakko Kogyo Co., Ltd., Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Gre\u0301goire","sequence":"additional","affiliation":[{"name":"From the Neuroscience Research Unit (Drs. GrondinBe\u0301dard, and Hadj Tahar, and L. Gre\u0301goire), Laval University Research Center, Quebec, Canada; and Pharmaceuticals Research and Development Center (Drs. Mori and Kase), Kyowa Hakko Kogyo Co., Ltd., Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mori","sequence":"additional","affiliation":[{"name":"From the Neuroscience Research Unit (Drs. GrondinBe\u0301dard, and Hadj Tahar, and L. Gre\u0301goire), Laval University Research Center, Quebec, Canada; and Pharmaceuticals Research and Development Center (Drs. Mori and Kase), Kyowa Hakko Kogyo Co., Ltd., Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kase","sequence":"additional","affiliation":[{"name":"From the Neuroscience Research Unit (Drs. GrondinBe\u0301dard, and Hadj Tahar, and L. Gre\u0301goire), Laval University Research Center, Quebec, Canada; and Pharmaceuticals Research and Development Center (Drs. Mori and Kase), Kyowa Hakko Kogyo Co., Ltd., Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.5.3260"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(83)90591-7"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(84)90009-0"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(90)80638-Y"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0022-3565(25)20519-5","volume":"259","year":"1991","unstructured":"Nikodijevic O, Sarges R, Daly JW, Jacobson KA. Behavioral effects of A1- and A2-selective adenosine agonists and antagonists : evidence for synergism and antagonism. J Pharmacol Exp Ther 1991;259:286\u2013294.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432506"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(86)90162-0"},{"key":"e_1_3_2_9_2","first-page":"419","volume":"90","year":"1986","unstructured":"Spealman RD, Coffin VL. Behavioral effects of adenosine analogs in squirrel monkeys : relation to adenosine A2 receptor. Psychopharmacology (Berl) 1986;90:419\u2013421.","journal-title":"Psychopharmacology (Berl)"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90064-W"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244078"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90438-3"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00735878"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)90925-D"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0022-3565(25)10554-5","volume":"274","year":"1995","unstructured":"Garrett BE, Holtzman SG. Does adenosine receptor blockade mediate caffeine-induced rotational behavior? J Pharmacol Exp Ther 1995;274:207\u2013214.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1996.tb01285.x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(96)00944-2"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1979.tb05236.x"},{"key":"e_1_3_2_19_2","first-page":"69","volume":"1","year":"1983","unstructured":"Daly JW, Butts-Lamb P, Padgett W. Subclasses of adenosine receptors in the central nervous system : interaction with caffeine and related methylxanthines. Cell Mol Neurobiol 1983;1:69\u201380.","journal-title":"Cell Mol Neurobiol"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0026-895X(25)10259-9","volume":"29","year":"1986","unstructured":"Bruns RF, Lu GH, Pugsley TA. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rats striatal membranes. Mol Pharmacol 1986;29:331\u2013346.","journal-title":"Mol Pharmacol"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(25)06782-1","volume":"46","year":"1994","unstructured":"Fredholm BB, Abbracchio MP, Burnstock G, et al. Nomenclature and classification of purinoceptors. Pharmacol Rev 1994;46:143\u2013156.","journal-title":"Pharmacol Rev"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.35.040195.003053"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.66010362.x"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)90097-U"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(91)90391-6"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(89)90571-2"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(91)90038-P"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(92)90173-9"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)91204-6"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1991.tb08257.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(94)90048-5"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(96)80010-1"},{"key":"e_1_3_2_33_2","first-page":"120.","volume":"12","year":"1997","unstructured":"Nonaka H, Saki M, Ichimura M, Kase H. Novel potent adenosine A2A receptor antagonists. Mov Disord 1997;12 (suppl 1):120. Abstract.","journal-title":"Mov Disord"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90551-7"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430415"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.16.7238"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(92)91036-E"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(95)00168-I"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/277093a0"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1990.tb08817.x"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1994.tb16171.x"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.16-02-00605.1996"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-3565(25)39350-X","volume":"267","year":"1993","unstructured":"Blanchet P, B\u00e9dard PJ, Britton DR, Kebabian JW. Differential effect of selective D1 and D2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys. J Pharmacol Exp Ther 1993;267:275\u2013279.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.2.421"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.52.8.1673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T22:46:07Z","timestamp":1743115567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.52.8.1673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["10.1212\/WNL.52.8.1673"],"URL":"https:\/\/doi.org\/10.1212\/wnl.52.8.1673","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}